NCT02953041View on ClinicalTrials.gov

Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 9, 2017

Conditions
Asthma
Interventions
DRUG

Glycopyrronium

long-acting muscarinic antagonist

DRUG

Indacaterol

ultra long-acting beta agonist

Trial Locations (1)

S7N 0W8

Asthma Research Lab, University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER

NCT02953041 - Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve | Biotech Hunter | Biotech Hunter